Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Elite Pharmaceuticals's Enterprise Value is $143.54 Mil.
Elite Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.69 Mil. Therefore, Elite Pharmaceuticals's EV-to-EBIT ratio for today is -85.19.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Elite Pharmaceuticals's Enterprise Value is $143.54 Mil.
Elite Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.32 Mil. Therefore, Elite Pharmaceuticals's EV-to-EBITDA ratio for today is -443.03.
Elite Pharmaceuticals Enterprise Value Historical Data
The historical data trend for Elite Pharmaceuticals's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Elite Pharmaceuticals's Enterprise Value
For the Drug Manufacturers - Specialty & Generic subindustry, Elite Pharmaceuticals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elite Pharmaceuticals's Enterprise Value Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Elite Pharmaceuticals's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Elite Pharmaceuticals's Enterprise Value falls into.
Elite Pharmaceuticals Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Elite Pharmaceuticals's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elite Pharmaceuticals (OTCPK:ELTP) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Elite Pharmaceuticals's current Enterprise Value is $143.54 Mil.
Elite Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.69 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Elite Pharmaceuticals's EV-to-EBITDA for today is:
Elite Pharmaceuticals's current Enterprise Value is $143.54 Mil.
Elite Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.32 Mil.
Elite Pharmaceuticals's current Enterprise Value is $143.54 Mil.
Elite Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $47.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elite Pharmaceuticals Enterprise Value Related Terms
Thank you for viewing the detailed overview of Elite Pharmaceuticals's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Elite Pharmaceuticals (Elite Pharmaceuticals) Business Description
Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELTP has been successfully added to your 